Beat the Beep: A New Cadence for Diabetes Management in Canada

📊 Key Data
  • 10%: Prevalence of diabetes in Canada as of 2024
  • 27%: Rise in diabetes-related medication prescriptions over four years
  • USD 2 billion: Value of the Canadian diabetes devices market in 2025
🎯 Expert Consensus

Experts would likely conclude that the 'Beat the Beep' campaign effectively reframes diabetes management by leveraging CGM technology to empower patients, shifting from reactive to proactive care while navigating strict health advertising regulations.

4 days ago
Beat the Beep: A New Cadence for Diabetes Management in Canada

Beat the Beep: A New Cadence for Diabetes Management in Canada

MONTREAL, QC – April 23, 2026 – For millions of Canadians living with diabetes, the sudden, insistent beep of a continuous glucose monitor (CGM) is a familiar, if unwelcome, sound. It’s a digital alarm signaling a drop in blood sugar, a moment that demands immediate action to prevent a hypoglycemic episode. Now, a groundbreaking marketing campaign is seeking to transform that moment of anxiety into one of proactive empowerment.

Montreal-based creative agency THE UN KNOWN® has partnered with AMG Medical to launch “Beat the Beep,” the first major Canadian consumer campaign for DEX4, a line of fast-acting glucose tablets. The campaign reframes the relationship between patient and technology, encouraging individuals not just to react to the alarm, but to get ahead of it, fundamentally changing the daily management of their condition.

A Campaign Anchored in Lived Experience

The core insight behind “Beat the Beep” emerged from a simple but profound observation of how people use modern diabetes technology. The creative team at THE UN KNOWN® identified the CGM alert as a pivotal, emotionally charged event in a user's day. This sound, while a vital safety feature, is also a source of stress and disruption.

“The beep is a signal that calls for an immediate response,” said Fayçal Hajji, Founder and CEO of THE UN KNOWN®, in a statement announcing the campaign. “The whole campaign is built on that lived reality for people with diabetes. That understanding guided the entire creative process… with the intent to translate a critical moment into a message that is simple, clear, and directly useful in daily life.”

The resulting strategy is elegantly simple: instead of waiting for the alarm, use the data from the CGM to anticipate a drop and take DEX4 glucose tablets proactively. This shifts the narrative from a reactive, emergency response to a controlled, planned action. The campaign, which includes two 30-second films and a suite of digital assets, visualizes this by turning a moment of potential vulnerability into a confident, reflexive action. It’s a message of empowerment, suggesting that individuals can take control and literally “beat the beep.”

Navigating a Complex and Growing Market

The launch of “Beat the Beep” is strategically timed, entering a Canadian diabetes care market that is not only growing but also rapidly evolving. The prevalence of diabetes in Canada has climbed to 10% as of 2024, with prescriptions for related medications rising by 27% in just four years. This demographic trend is coupled with a technological shift. The Canadian market for diabetes devices, valued at over USD 2 billion in 2025, is seeing significant growth in the adoption of CGM systems—the very technology at the heart of the campaign.

By focusing on the specific experience of CGM users, AMG Medical and THE UN KNOWN® are targeting a sophisticated and growing segment of the diabetes community. This niche focus allows DEX4 to differentiate itself from other fast-acting glucose sources like juice or candy, positioning it as a precise, clinical tool for modern diabetes management.

“By anchoring our strategy in the reality of how new technologies like CGMs are used, we've successfully positioned DEX4 as the precise, fast-acting solution to get back in range,” noted Corina Ilia, Senior VP of Marketing & Strategy at AMG Medical. She confirmed the strategy is paying off, citing “outstanding brand growth” and high social media engagement that indicates the message is resonating deeply within the community.

The Art of Messaging in a Regulated Space

Advertising any health product in Canada is a complex undertaking, governed by stringent regulations from Health Canada and Ad Standards Canada. The Food and Drugs Act explicitly prohibits advertising a cure for serious conditions like diabetes to the general public. This regulatory landscape demands a careful, nuanced approach that prioritizes clarity and avoids misleading claims.

The “Beat the Beep” campaign serves as a case study in effective communication within these constraints. The messaging is intentionally “direct, concrete, and immediately understandable.” It makes no claims of a cure; instead, it focuses on disease management and patient empowerment. By framing DEX4 as a tool to “get back in range” and manage hypoglycemic episodes, the campaign aligns with guidelines that permit educational and help-seeking messages.

This success highlights the agency's ability to navigate what it calls “heavy regulatory constraints and the sensitivity of health messaging.” The pan-Canadian rollout, which includes a dedicated microsite, an optimized Amazon storefront, and a broad digital activation, was fully conceived and produced by THE UN KNOWN®, demonstrating a comprehensive command of both creative development and compliant execution in the digital age.

From Production House to Strategic Powerhouse

The DEX4 campaign marks a significant milestone for THE UN KNOWN®, cementing its evolution from an integrated production house founded in 2010 to a formidable creative agency and consultancy. After a competitive review process, AMG Medical awarded the agency a full-scope mandate that spanned from high-level brand strategy to the granular details of film production and e-commerce deployment.

This victory validates the agency’s model as a “next-gen consultancy where strategy, creativity, production and technology converge.” Operating with a “human-led and AI-amplified” approach, the firm has demonstrated its ability to win and execute major national mandates for ambitious brands in complex sectors. The campaign's success is a testament to its strategic depth, moving beyond traditional advertising to build a complete ecosystem that engages consumers across digital and transactional platforms, amplified by media partners at Substance and an influencer strategy led by Marc-André Duschenes.

For the millions of Canadians managing diabetes, the campaign offers more than just a product; it offers a new perspective. By understanding and addressing the real-world anxieties of its audience, “Beat the Beep” has created a powerful message of control and confidence, proving that the most effective marketing is often the most empathetic.

Sector: Diagnostics Financial Services
Theme: Cloud Migration
Event: Corporate Action
Product: Pharmaceuticals & Therapeutics
Metric: Revenue

📝 This article is still being updated

Are you a relevant expert who could contribute your opinion or insights to this article? We'd love to hear from you. We will give you full credit for your contribution.

Contribute Your Expertise →
UAID: 27471